Mayne, Cosette row to be decided on merits after panel resets merger clock

M&A 2025-11-14 11:56 pm By Cat Fredenburgh

Make us a preferred source Make us a preferred source on Google

The Takeovers Panel has agreed to hear Mayne Pharma’s latest dispute with Cosette over the US drug maker’s attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.